DaVita Inc. (0I7E.L)
USD 150.4
(2.83%)
USD 150.4
(2.83%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 11.11 Billion USD | -5.97% |
| 2022 | 11.82 Billion USD | -1.28% |
| 2021 | 11.97 Billion USD | 6.98% |
| 2020 | 11.19 Billion USD | 0.16% |
| 2019 | 11.17 Billion USD | 10.63% |
| 2018 | 10.1 Billion USD | 8.2% |
| 2017 | 9.33 Billion USD | 2.46% |
| 2016 | 9.11 Billion USD | -0.2% |
| 2015 | 9.13 Billion USD | 7.37% |
| 2014 | 8.5 Billion USD | 1.04% |
| 2013 | 8.41 Billion USD | -1.62% |
| 2012 | 8.55 Billion USD | 89.89% |
| 2011 | 4.5 Billion USD | 3.94% |
| 2010 | 4.33 Billion USD | 18.32% |
| 2009 | 3.66 Billion USD | -0.87% |
| 2008 | 3.69 Billion USD | -0.33% |
| 2007 | 3.7 Billion USD | -1.17% |
| 2006 | 3.75 Billion USD | -9.77% |
| 2005 | 4.15 Billion USD | 202.16% |
| 2004 | 1.37 Billion USD | 17.84% |
| 2003 | 1.16 Billion USD | -11.5% |
| 2002 | 1.31 Billion USD | 60.84% |
| 2001 | 820.22 Million USD | -15.93% |
| 2000 | 975.68 Million USD | 2922.47% |
| 1999 | 32.28 Million USD | -97.41% |
| 1998 | 1.24 Billion USD | 247.91% |
| 1997 | 358.6 Million USD | 242.5% |
| 1996 | 104.7 Million USD | 87.3% |
| 1995 | 55.9 Million USD | -36.55% |
| 1994 | 88.1 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 11.67 Billion USD | -1.4% |
| 2024 Q3 | 9.55 Billion USD | 4.48% |
| 2024 Q1 | 11.84 Billion USD | 6.52% |
| 2023 Q4 | 11.11 Billion USD | -0.12% |
| 2023 FY | 11.11 Billion USD | -5.97% |
| 2023 Q2 | 11.47 Billion USD | -0.27% |
| 2023 Q1 | 11.5 Billion USD | -2.65% |
| 2023 Q3 | 11.12 Billion USD | -3.04% |
| 2022 Q3 | 12.03 Billion USD | -1.88% |
| 2022 Q4 | 11.82 Billion USD | -1.78% |
| 2022 FY | 11.82 Billion USD | -1.28% |
| 2022 Q1 | 11.89 Billion USD | -0.68% |
| 2022 Q2 | 12.26 Billion USD | 3.13% |
| 2021 Q4 | 11.97 Billion USD | -0.56% |
| 2021 FY | 11.97 Billion USD | 6.98% |
| 2021 Q1 | 12.11 Billion USD | 8.18% |
| 2021 Q2 | 12.09 Billion USD | -0.15% |
| 2021 Q3 | 12.04 Billion USD | -0.41% |
| 2020 Q2 | 12.87 Billion USD | 10.21% |
| 2020 Q1 | 11.67 Billion USD | 4.5% |
| 2020 Q3 | 11.1 Billion USD | -13.71% |
| 2020 Q4 | 11.19 Billion USD | 0.79% |
| 2020 FY | 11.19 Billion USD | 0.16% |
| 2019 Q2 | 12.03 Billion USD | -10.6% |
| 2019 Q1 | 13.45 Billion USD | 33.21% |
| 2019 Q3 | 11.19 Billion USD | -6.97% |
| 2019 Q4 | 11.17 Billion USD | -0.15% |
| 2019 FY | 11.17 Billion USD | 10.63% |
| 2018 Q1 | 9.46 Billion USD | 1.37% |
| 2018 FY | 10.1 Billion USD | 8.2% |
| 2018 Q4 | 10.1 Billion USD | -1.2% |
| 2018 Q3 | 10.22 Billion USD | 2.82% |
| 2018 Q2 | 9.94 Billion USD | 5.07% |
| 2017 Q4 | 9.33 Billion USD | 2.61% |
| 2017 FY | 9.33 Billion USD | 2.46% |
| 2017 Q1 | 9.08 Billion USD | -0.26% |
| 2017 Q2 | 9.09 Billion USD | 0.04% |
| 2017 Q3 | 9.09 Billion USD | 0.06% |
| 2016 FY | 9.11 Billion USD | -0.2% |
| 2016 Q4 | 9.11 Billion USD | -0.14% |
| 2016 Q3 | 9.12 Billion USD | 0.26% |
| 2016 Q2 | 9.1 Billion USD | -0.18% |
| 2016 Q1 | 9.11 Billion USD | -0.14% |
| 2015 FY | 9.13 Billion USD | 7.37% |
| 2015 Q1 | 8.49 Billion USD | -0.06% |
| 2015 Q3 | 9.19 Billion USD | -0.14% |
| 2015 Q4 | 9.13 Billion USD | -0.72% |
| 2015 Q2 | 9.2 Billion USD | 8.37% |
| 2014 Q3 | 8.5 Billion USD | -3.38% |
| 2014 FY | 8.5 Billion USD | 1.04% |
| 2014 Q2 | 8.79 Billion USD | 5.21% |
| 2014 Q1 | 8.36 Billion USD | -0.62% |
| 2014 Q4 | 8.5 Billion USD | 0.01% |
| 2013 Q2 | 8.47 Billion USD | -0.34% |
| 2013 Q4 | 8.41 Billion USD | -0.3% |
| 2013 FY | 8.41 Billion USD | -1.62% |
| 2013 Q3 | 8.44 Billion USD | -0.42% |
| 2013 Q1 | 8.5 Billion USD | -0.57% |
| 2012 Q3 | 5.73 Billion USD | 27.57% |
| 2012 Q1 | 4.49 Billion USD | -0.3% |
| 2012 FY | 8.55 Billion USD | 89.89% |
| 2012 Q4 | 8.55 Billion USD | 49.07% |
| 2012 Q2 | 4.49 Billion USD | 0.15% |
| 2011 FY | 4.5 Billion USD | 3.94% |
| 2011 Q4 | 4.5 Billion USD | 0.11% |
| 2011 Q3 | 4.49 Billion USD | 4.99% |
| 2011 Q2 | 4.28 Billion USD | -0.71% |
| 2011 Q1 | 4.31 Billion USD | 0.19% |
| 2010 Q2 | 3.41 Billion USD | -6.21% |
| 2010 Q1 | 3.63 Billion USD | -0.68% |
| 2010 Q3 | 3.38 Billion USD | -0.67% |
| 2010 Q4 | 4.3 Billion USD | 27.14% |
| 2010 FY | 4.33 Billion USD | 18.32% |
| 2009 Q4 | 3.66 Billion USD | -0.7% |
| 2009 Q1 | 3.71 Billion USD | 0.62% |
| 2009 Q2 | 3.67 Billion USD | -1.25% |
| 2009 Q3 | 3.68 Billion USD | 0.46% |
| 2009 FY | 3.66 Billion USD | -0.87% |
| 2008 FY | 3.69 Billion USD | -0.33% |
| 2008 Q1 | 3.7 Billion USD | -0.05% |
| 2008 Q2 | 3.7 Billion USD | 0.1% |
| 2008 Q3 | 3.7 Billion USD | -0.05% |
| 2008 Q4 | 3.69 Billion USD | -0.33% |
| 2007 FY | 3.7 Billion USD | -1.17% |
| 2007 Q4 | 3.7 Billion USD | 0.05% |
| 2007 Q1 | 3.75 Billion USD | 0.11% |
| 2007 Q2 | 3.7 Billion USD | -1.27% |
| 2007 Q3 | 3.7 Billion USD | -0.07% |
| 2006 Q4 | 3.75 Billion USD | -1.92% |
| 2006 Q3 | 3.82 Billion USD | -3.02% |
| 2006 Q2 | 3.94 Billion USD | -2.49% |
| 2006 Q1 | 4.04 Billion USD | -2.71% |
| 2006 FY | 3.75 Billion USD | -9.77% |
| 2005 Q4 | 4.15 Billion USD | 204.55% |
| 2005 Q3 | 1.36 Billion USD | -0.06% |
| 2005 FY | 4.15 Billion USD | 202.16% |
| 2005 Q2 | 1.36 Billion USD | -0.18% |
| 2005 Q1 | 1.36 Billion USD | -0.54% |
| 2004 Q3 | 1.38 Billion USD | 21.31% |
| 2004 FY | 1.37 Billion USD | 17.84% |
| 2004 Q1 | 1.15 Billion USD | -1.05% |
| 2004 Q4 | 1.37 Billion USD | -0.87% |
| 2004 Q2 | 1.14 Billion USD | -0.97% |
| 2003 FY | 1.16 Billion USD | -11.5% |
| 2003 Q4 | 1.16 Billion USD | -11.74% |
| 2003 Q3 | 1.32 Billion USD | -9.21% |
| 2003 Q2 | 1.45 Billion USD | -0.51% |
| 2003 Q1 | 1.46 Billion USD | 11.01% |
| 2002 Q3 | 1.32 Billion USD | -0.18% |
| 2002 Q4 | 1.31 Billion USD | -0.21% |
| 2002 Q2 | 1.32 Billion USD | 65.49% |
| 2002 Q1 | 800.3 Million USD | -2.43% |
| 2002 FY | 1.31 Billion USD | 60.84% |
| 2001 Q4 | 820.22 Million USD | -0.02% |
| 2001 FY | 820.22 Million USD | -15.93% |
| 2001 Q3 | 820.4 Million USD | -13.7% |
| 2001 Q1 | 939.6 Million USD | -3.7% |
| 2001 Q2 | 950.66 Million USD | 1.18% |
| 2000 Q1 | 28.93 Million USD | -10.38% |
| 2000 Q3 | 1.08 Billion USD | -17.32% |
| 2000 Q4 | 975.68 Million USD | -9.87% |
| 2000 Q2 | 1.3 Billion USD | 4425.84% |
| 2000 FY | 975.68 Million USD | 2922.47% |
| 1999 Q1 | 1.34 Billion USD | 7.74% |
| 1999 Q4 | 32.28 Million USD | -97.79% |
| 1999 Q3 | 1.45 Billion USD | 1.76% |
| 1999 FY | 32.28 Million USD | -97.41% |
| 1999 Q2 | 1.43 Billion USD | 6.58% |
| 1998 Q4 | 1.24 Billion USD | 8.47% |
| 1998 Q1 | 937.8 Million USD | 161.52% |
| 1998 Q3 | 1.15 Billion USD | 9.47% |
| 1998 FY | 1.24 Billion USD | 247.91% |
| 1998 Q2 | 1.05 Billion USD | 12.04% |
| 1997 Q1 | 102.5 Million USD | -2.1% |
| 1997 Q2 | 192.1 Million USD | 87.41% |
| 1997 Q3 | 253.9 Million USD | 32.17% |
| 1997 Q4 | 358.6 Million USD | 41.24% |
| 1997 FY | 358.6 Million USD | 242.5% |
| 1996 FY | 104.7 Million USD | 87.3% |
| 1996 Q4 | 104.7 Million USD | 32.53% |
| 1996 Q2 | 59.1 Million USD | -45.18% |
| 1996 Q1 | 107.8 Million USD | 96.0% |
| 1996 Q3 | 79 Million USD | 33.67% |
| 1995 Q2 | 88.1 Million USD | 0.0% |
| 1995 Q3 | 101.2 Million USD | 14.87% |
| 1995 FY | 55.9 Million USD | -36.55% |
| 1995 Q4 | 55 Million USD | -45.65% |
| 1994 FY | 88.1 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Phreesia, Inc. | 11.98 Million USD | -92668.263% |
| Accuray Incorporated | 172.15 Million USD | -6357.179% |
| Align Technology, Inc. | 96.96 Million USD | -11364.01% |
| Elevance Health Inc. | 25.12 Billion USD | 55.747% |
| AxoGen, Inc. | 69.29 Million USD | -15942.864% |
| Boston Scientific Corporation | 9.09 Billion USD | -22.199% |
| CVS Health Corporation | 79.38 Billion USD | 85.997% |
| Cardinal Health, Inc. | 5.6 Billion USD | -98.189% |
| Centene Corporation | 17.69 Billion USD | 37.192% |
| HCA Healthcare, Inc. | 41.85 Billion USD | 73.443% |
| Hologic, Inc. | 2.53 Billion USD | -338.587% |
| Humana Inc. | 10.21 Billion USD | -8.846% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | -1072.767% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | -86.699% |
| Masimo Corporation | 970 Million USD | -1046.023% |
| McKesson Corporation | 5.47 Billion USD | -103.151% |
| Patterson Companies, Inc. | 762.94 Million USD | -1357.05% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | -107.048% |
| ResMed Inc. | 873.93 Million USD | -1171.996% |
| Henry Schein, Inc. | 2.74 Billion USD | -305.561% |
| Teladoc Health, Inc. | 1.59 Billion USD | -598.146% |
| Universal Health Services, Inc. | 5.36 Billion USD | -107.14% |
| Veeva Systems Inc. | 55.77 Million USD | -19830.831% |
| Baxter International Inc. | 14.36 Billion USD | 22.609% |
| Becton, Dickinson and Company | 15.87 Billion USD | 29.993% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -12279.088% |
| Danaher Corporation | 19.35 Billion USD | 42.569% |
| Stryker Corporation | 12.99 Billion USD | 14.456% |
| Medtronic plc | 24.96 Billion USD | 55.468% |